TEXERE BIOTECH
The world’s first fully robotic line offering revolutionary improvements
in the processing of human tissue.
Healthcare around the world is facing growing challenges: aging population, increasing burden of diseases, but also waste of resources and in particular precious human tissue. Global healthcare spending is expected to continue growing. The current technologies are struggling to deliver high-quality and affordable products that returns people to fuller and more productive lives. Our robotized advanced machining process recycles human tissue from donor and make them the source of the quality allograft for repairing, replacing, restoring and regenerating tissue for receiving patient.
Advanced technology for producing bone allograft
TEXERE Biotech is bringing innovative technology solution for the processing of human tissue, in particular for the production of bone allograft.
OUR VISION
Our vision is to use advanced automation and robotized technologies to contribute to solve healthcare challenges: providing a better access, improve outcomes of patient care to restore health and extend life for patient around the world.
OUR MISSION
Our mission is to build forefront robotization processing lines to drive progress and innovation for recycling of human tissue.
OUR PROPOSAL
Our automation process recycles human tissue from donor and make them the source of quality allograft for repairing, replacing, restoring and regenerating tissue for receiving patient.
Processing services
PROCESSING BONE ALLOGRAFT
We offer sub-contracting services to bone banks for processing their collected femoral heads for processing into freeze-dried bone allograft (FDBA) blocks.
SAFETY & RELIABILITY
Bone tissue is processed by our unique robotized advanced machining BONEFIDE® process.
COMPLETE TRACEABILITY
Our BONEFIDE® process has been developed based on GMP guidelines and does provide full traceability for each produced bone allograft block.
technology provider
GLOBAL TURNKEY SOLUTION
Our automated robotized and compact processing line is available as a plug-in/ready-to-start turnkey solution for export. The line is build in maritime containers and fully qualified prior to shipment.
TECHNOLOGY TRANSFER
We do provide with each processing line the complete technology transfer and training of your personnel, so that you can start your production without any delay.
LICENSING AGREEMENT
Our technology is continuously being improved and throughout our licensing agreement, that is included within each turnkey project, you have the guarantee to stay up to date with our advanced tissue processing technology.
BONEFIDE®
Respecting bone tissue
BONEFIDE® is an advanced machining, fully automated and robotized process, to treat human tissues in view to guarantee:
- the integrity of the ultrastructure and the biological properties of bone
- the safety by eliminating all risks of cross-contamination
Our team
WHO we are
TEXERE Biotech, a Belgium based company incorporated in 2016, has been co-founded by three partners.
These partners have joined their various medical, industrial and robotics expertise with the vision to use advanced automated technologies (known as “smart factory-industry 4.0”) to contribute to solve today’s and future healthcare challenges by:
- providing a better access,
- improve outcomes,
of patient care to restore health and extend life for people around the world.
Latest news
WAB magazine n°40 – Spring 2019
Walloon start-up Texere Biotech has created the world’s first automated robotic bone graft production system, which revolutionises the processing of human tissue.
Wallonia.BE – 30 Mar 2019
Wallonia.BE – 30 Mar 2019 Fully robotic processing of human tissue by TEXERE BiotechThis is a world first: a Walloon company producing bone grafts from beginning to end, from raw human tissue to the labelling of the final product using artificial intelligence combined with robots. These cube-shaped grafts are used for restorative bone surgery such […]
Trends Tendances, 28 Mar 2019
Texere Biotech, des tissus haute technologie. Texere Biotech a développé une ligne de production automatisée de greffons osseux.
Revue Athena no. 340 pg 8, Jan-Feb 2019
Revue Athena no. 340 pg 8, Jan-Feb 2019 La ligne robotisée la plus avancée du monde est wallonne. Inaugurée à Charleroi dans les installations de TEXERE Biotech, elle produit des greffons osseux. Bonne nouvelle car l’os est le deuxième tissu le plus transplanté après le sang.[…]
Wallonia.be, 8 Jan2019
Fin 2018, la start-up TEXERE Biotech, située à Frasnes-lez-Gosselies au nord de Charleroi, a fait le buzz : elle inaugurait la première ligne au monde entièrement robotisée de production de greffons osseux. Une ligne 100% wallonne et une révolution dans le domaine !
Frankfurter Allgemeine Zeitung, 27 Dec 2018
Neue Lebenszeichen in Walloniens “Silicon Valley des 19. Jahrhunderts”:
“Texere bedeutet nicht das Ende der Gewebebanken. Wir wollen die Behandlung des Gewebes beschleunigen,
zuverlässiger machen und zu niedrigeren Kosten beitragen”, erklärt Dufrane.
RTBF, JT 13h, 16 Dec 2018
C’est une grande première dans le domaine médical.
Une société carolo à créé une ligne de découpe de tissus osseux.
Daily Science, 13 Dec 2018
Des robots et des os à Frasnes-lez-Gosselies.
L’Avenir, 13 Dec 2018
Des robots rabotent des bouts d’os.
L’Avenir, 13 Dec 2018
Un projet 100% wallon.
L’Echo, 13 Dec 2018
Texere Biotech dévoile une ligne de production de greffons osseux.
Trends-Tendances, 12 Dec 2018
Les robots de la greffe d’os.
RTL-TVI, INFO 19h, 12 Dec 2018
Une première mondiale près de Charleroi.